Welcome
Support Centre
22 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ ...Back to search results ] [ Print-friendly version ]
Acute endovascular treatment to improve outcome of ruptured aorto-iliac aneurysms
ISRCTN ISRCTN66212637
ClinicalTrials.gov identifier
Public title Acute endovascular treatment to improve outcome of ruptured aorto-iliac aneurysms
Scientific title
Acronym The AJAX trial
Serial number at source NTR85; 2002B197
Study hypothesis Acute endovascular treatment improves outcome of ruptured aorto-iliac aneurysms.

Please note that as of 19/10/2007 the anticipated end date of this trial was extended from 01/10/2007 to 01/08/2008.

As of 12/09/2008 the anticipated end date was again extended to 01/10/2010. At this time, the record was also updated to include an enlarged target number of participants. The previous target number of participants was 80.

Patient inclusion completed with 116 patients on 17/02/2011
Lay summary
Ethics approval Ethics approval received from the MEC of the Academic Medical Center in Amsterdam (certified MEC) on the 28th August 2003 (ref: MEC 03/161). A protocol amendment was approved on 26th November 2008.
Study design Randomised controlled trial
Countries of recruitment Netherlands
Disease/condition/study domain Ruptured aorto-iliac aneurysms
Participants - inclusion criteria 1. Ruptured aneurysm (diagnosed by computed tomography [CT]-angiography)
2. Anatomical criteria:
2.1. Adequate infrarenal aortic neck
2.2. Adequate iliac anatomy

Added 12/01/2009:
3. Patients greater than 18 years male or female
Participants - exclusion criteria 1. Symptomatic aneurysm (no rupture)
2. Asymptomatic aneurysm
3. Juxtarenal aneurysm
4. Anatomical unsuitability
5. Patient unfit for open procedure
6. Extreme instability of the patient making CT-angiography impossible
Anticipated start date 05/04/2004
Anticipated end date 01/10/2010
Status of trial Completed
Patient information material Patient information material can be found at: http://www.amc.nl/index.cfm?pid=1132 (in Dutch only)
Target number of participants 80 (this was amended on 12/01/2009 to 120 participants)
Interventions CT angiography: all patients with suspected rupture of an abdominal aortic aneurysm will be examined by CT angiography to confirm the diagnosis of a ruptured aneurysm and to evaluate the anatomical suitability for endovascular treatment. The patient is entered in the study if the aneurysm is ruptured, the anatomical criteria for endovascular repair are fulfilled and the patient is fit for an open procedure. Patients will then be randomised for either open or endovascular treatment. If possible informed consent is obtained, if the clinical condition of the patient does not allow for a proper informed consent, informed consent will be asked after the patient has been treated (in accordance with Dutch Law: WMO §2, artikel 6-1).

Open procedure: patient under general anesthesia, laparotomy, standard aortic repair with either an aortic tube graft or a bifurcated graft, standard closure.

Endovascular procedure: Local anesthesia of both groin regions, dissection of the common femoral arteries, placement of aorto-uni-iliac endovascular graft through one of the femoral arteries and placement of an iliac occluder in the contralateral iliac artery, placement of a femoro-femoral cross-over bypass.
Primary outcome measure(s) Mortality and severe morbidity, measured at 30 days, 3 months, 6 months.
Secondary outcome measure(s) 1. Quality of life, measured at 30 days, 3 months, 6 months
2. Length of intensive care stay, measured at 30 days, 3 months, 6 months
3. Cost-effectiveness, measured at 30 days, 3 months, 6 months
Sources of funding Netherlands Heart Foundation (Nederlandse Hartstichting) (Netherlands) (ref: 2002B197)
Trial website http://www.amc.nl/index.cfm?sid=324
Publications 1. Background, design, methods on http://www.ncbi.nlm.nih.gov/pubmed/16956484
2. Prospective cohort paper on http://www.ncbi.nlm.nih.gov/pubmed/17276096
Contact name Dr  R  Balm
  Address Academic Medical Centre
Department of Vascular Surgery G4-111.1
Meibergdreef 9
  City/town Amsterdam
  Zip/Postcode 1105 AZ
  Country Netherlands
  Tel +31 (0)20 5667832
  Fax +31 (0)20 5669243
  Email r.balm@amc.nl
Sponsor Academic Medical Centre (AMC) (Netherlands)
  Address Department of Vascular Surgery
Meibergdreef 9
  City/town Amsterdam
  Zip/Postcode 1105 AZ
  Country Netherlands
  Sponsor website: http://www.amc.uva.nl
Date applied 12/09/2005
Last edited 24/02/2011
Date ISRCTN assigned 12/09/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central